Takeda Pharmaceutical (TAK) Change in Taxes (2018 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Change in Taxes of -$106.0 million for Q2 2026, up 58.14% year-over-year from -$67.0 million in Q2 2025, and up 74.21% quarter-over-quarter from -$411.1 million in Q1 2026.
Takeda Pharmaceutical (TAK) Change in Taxes (2018 - 2026) Analysis & Trends
Takeda Pharmaceutical's Change in Taxes history runs 9 years deep, the most recent figure standing at -$106.0 million for Q2 2026.
- In Q2 2026, Change in Taxes rose 58.14% year-over-year to -$106.0 million; the TTM figure through Jun 2026 stood at -$1.0 billion (up 7.4% YoY), while the FY2026 annual figure was -$1.2 billion, down 7.02% from the prior year.
- Change in Taxes for Q2 2026 stood at -$106.0 million, up from -$411.1 million in the prior quarter.
- The five-year high for Change in Taxes was -$106.0 million in Q2 2026, with the low at -$655.2 million in Q3 2022.
- The 5-year median for Change in Taxes is -$334.7 million (2023), against an average of -$319.3 million.
- The sharpest annual moves came in 2023 and 2026: Change in Taxes plunged 111.5% in 2023, then jumped 58.14% in 2026.
- Takeda Pharmaceutical's Change in Taxes stood at -$410.1 million in 2022, then grew by 17.08% to -$340.0 million in 2023, then jumped by 39.51% to -$205.7 million in 2024, then rose by 24.06% to -$156.2 million in 2025, then soared by 32.12% to -$106.0 million in 2026.
- Business Quant data shows TAK's Change in Taxes at -$106.0 million in Q2 2026, -$411.1 million in Q1 2026, and -$156.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | -66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -106.03 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 40.90 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | -59.60 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -106.03 Mn |
| Jun 30, 2026 | -106.03 Mn |
| Mar 31, 2026 | -411.14 Mn |
| Mar 31, 2026 | -411.14 Mn |
| Dec 31, 2025 | -156.19 Mn |
| Dec 31, 2025 | -156.19 Mn |
| Sep 30, 2025 | -374.89 Mn |
| Sep 30, 2025 | -374.89 Mn |
| Jun 30, 2025 | -253.31 Mn |
| Jun 30, 2025 | -253.31 Mn |
| Mar 31, 2025 | -329.30 Mn |
| Mar 31, 2025 | -329.30 Mn |
| Dec 31, 2024 | -205.67 Mn |
| Dec 31, 2024 | -205.67 Mn |
| Sep 30, 2024 | -343.72 Mn |
| Sep 30, 2024 | -343.72 Mn |
| Jun 30, 2024 | -242.89 Mn |
| Jun 30, 2024 | -242.89 Mn |
| Mar 31, 2024 | -274.25 Mn |
| Mar 31, 2024 | -274.25 Mn |